about
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.The heart in vasculitis.Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumaticaTrial of Tocilizumab in Giant-Cell Arteritis
P50
description
researcher ORCID ID = 0000-0002-8935-7473
@en
name
Sebastian Unizony
@ast
Sebastian Unizony
@en
Sebastian Unizony
@es
Sebastian Unizony
@nl
type
label
Sebastian Unizony
@ast
Sebastian Unizony
@en
Sebastian Unizony
@es
Sebastian Unizony
@nl
prefLabel
Sebastian Unizony
@ast
Sebastian Unizony
@en
Sebastian Unizony
@es
Sebastian Unizony
@nl
P31
P496
0000-0002-8935-7473